DONALD BONS: Open Payments
NPI 1073946711 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 13 payments from 9 companies in 2025. Trend: 2023 $138 · 2024 $0 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $96 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
Products named: REPATHA, EVENITY, TRELEGY ELLIPTA, JARDIANCE, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, Ozempic, GVOKE HYPOPEN, The Cologuard Plus Collection Kit.
Industry payments across OR — which companies pay providers there.
